ArticleInfection2026
Clinical burden of acute respiratory infections in children < 5 years in the emergency room: results from the first season (2023/24) of the RISE study.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the role of acute respiratory infections (ARI) and its severity in emergency room (ER) visits in children.
methodsIn this study we assessed the attendance rate, hospitalization and pathogen epidemiology of ARI and proportion of lower/upper respiratory tract infections (LRTI/URTI) in a pediatric ER. From December 1, 2023 to May 30, 2024, patients aged < 60 months with ARI were recruited in a pediatric ER in Berlin. Nasopharyngeal multiplex real-time PCR was performed to identify respiratory pathogens.
results5019 patients < 60 months attended the ER, thereof 2025 (40.4%) had ARI, 168 were included (median age 19 months). 100 (59.5%) had URTI and 68 (40.5%) had LRTI. Pathogens were detected in 152 cases (mono- and co-infections), with a total of 209 pathogens identified: 48 (22.5%) detections of respiratory syncytial virus (RSV), 31 (14.4%) of influenza (FLU), 55 (26.3%) rhinovirus (RV), 1 RSV/FLU (0.5%), and 75 (35.9%) of other viral pathogens. RSV was found significantly more often in LRTI-cases, FLU in URTI-cases. Children with RSV were significantly younger than those with FLU or RV (median ages in months: RSV, 11; FLU, 31; RV, 20.5; p < 0.001 for pairwise comparisons with RSV). The overall hospitalization rate was 25.6%, predominantly due to LRTI (79.1%). Especially in RSV LRTI was dominant (100%) compared to FLU (40.0%) and RV (66.7%). Hospitalization rates differed significantly between pathogen groups (RSV = 42.5%, FLU = 16.7%, RV = 23.7%, p = 0.003).
conclusionsAmong young children RSV infections contribute significantly to ER visits as well as hospitalization in the ER cohort. Overall, prevention strategies of ARI may reduce patient burden in the ER and hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.